Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Dec;12(6):717–720. doi: 10.1128/aac.12.6.717

Clinical Pharmacology of Netilmicin

Boh-Seng Yap 1, Dorothy Stewart 1, Gerald P Bodey 1
PMCID: PMC430010  PMID: 931370

Abstract

Pharmacological studies of netilmicin were conducted in 30 cancer patients. After intravenous administration of 50 mg of netilmicin or gentamicin per m2 over a 1-h period in 10 patients, the mean peak serum concentrations occurred at the end of the infusion and were 7.6 and 7.3 μg/ml, respectively. At 6 h, the mean serum concentrations of both drugs was 1.1 μg/ml. After intramuscular injection of 50 mg of netilmicin per m2 to each of the same 10 patients, the mean peak serum concentration was 5.5 μg/ml and occurred at 1 h, and, at 6 h, the mean serum concentration was 1.4 μg/ml. The mean proportion of netilmicin excreted in urine during 6 h after intramuscular injection was 55%, and after intravenous injection it was 40.9%. Results were similar with gentamicin sulfate. After administering 60 mg of netilmicin per m2 intravenously over 30 min every 6 h in 9 patients, the mean peak serum concentration (7.9 μg/ml) occurred at the end of the infusion. The concentration gradually decreased to below 2.0 μg/ml after 4 h. Continuous infusion of 60 mg of netilmicin per m2 every 6 h after a 60-mg/m2 loading dose in 11 patients produced levels consistently above 2.9 μg/ml, during the initial 6-h infusion, and levels above 2.0 μg/ml for at least 1 week.

Full text

PDF
717

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Chang H. Y., Rodriguez V., Stewart D. Feasibility of administering aminoglycoside antibiotics by continuous intravenous infusion. Antimicrob Agents Chemother. 1975 Sep;8(3):328–333. doi: 10.1128/aac.8.3.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Kabins S. A., Nathan C., Cohen S. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics. Antimicrob Agents Chemother. 1976 Jul;10(1):139–145. doi: 10.1128/aac.10.1.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Luft F. C., Yum M. N., Kleit S. A. Comparative nephrotoxicities of netilmicin and gentamicin in rats. Antimicrob Agents Chemother. 1976 Nov;10(5):845–849. doi: 10.1128/aac.10.5.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Miller G. H., Arcieri G., Weinstein M. J., Waitz J. A. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. Antimicrob Agents Chemother. 1976 Nov;10(5):827–836. doi: 10.1128/aac.10.5.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Rahal J. J., Jr, Simberkoff M. S., Kagan K., Moldover N. H. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms. Antimicrob Agents Chemother. 1976 Apr;9(4):595–599. doi: 10.1128/aac.9.4.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Riff L. J., Moreschi G. Netilmicin and gentamicin: comparative pharmacology in humans. Antimicrob Agents Chemother. 1977 Apr;11(4):609–614. doi: 10.1128/aac.11.4.609. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES